Literature DB >> 20194438

Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression.

Teppei Yamaguchi1, Fabien Cubizolles, Yu Zhang, Nina Reichert, Hubertus Kohler, Christian Seiser, Patrick Matthias.   

Abstract

Histone deacetylases (HDACs) regulate gene expression by deacetylating histones and also modulate the acetylation of a number of nonhistone proteins, thus impinging on various cellular processes. Here, we analyzed the major class I enzymes HDAC1 and HDAC2 in primary mouse fibroblasts and in the B-cell lineage. Fibroblasts lacking both enzymes fail to proliferate in culture and exhibit a strong cell cycle block in the G1 phase that is associated with up-regulation of the CDK inhibitors p21(WAF1/CIP1) and p57(Kip2) and of the corresponding mRNAs. This regulation is direct, as in wild-type cells HDAC1 and HDAC2 are bound to the promoter regions of the p21 and p57 genes. Furthermore, analysis of the transcriptome and of histone modifications in mutant cells demonstrated that HDAC1 and HDAC2 have only partly overlapping roles. Next, we eliminated HDAC1 and HDAC2 in the B cells of conditionally targeted mice. We found that B-cell development strictly requires the presence of at least one of these enzymes: When both enzymes are ablated, B-cell development is blocked at an early stage, and the rare remaining pre-B cells show a block in G1 accompanied by the induction of apoptosis. In contrast, elimination of HDAC1 and HDAC2 in mature resting B cells has no negative impact, unless these cells are induced to proliferate. These results indicate that HDAC1 and HDAC2, by normally repressing the expression of p21 and p57, regulate the G1-to-S-phase transition of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194438      PMCID: PMC2827841          DOI: 10.1101/gad.552310

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  43 in total

1.  Negative and positive regulation of gene expression by mouse histone deacetylase 1.

Authors:  Gordin Zupkovitz; Julia Tischler; Markus Posch; Iwona Sadzak; Katrin Ramsauer; Gerda Egger; Reinhard Grausenburger; Norbert Schweifer; Susanna Chiocca; Thomas Decker; Christian Seiser
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

Review 2.  The p53 mutation "gradient effect" and its clinical implications.

Authors:  Gerard P Zambetti
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

3.  Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility.

Authors:  Rusty L Montgomery; Christopher A Davis; Matthew J Potthoff; Michael Haberland; Jens Fielitz; Xiaoxia Qi; Joseph A Hill; James A Richardson; Eric N Olson
Journal:  Genes Dev       Date:  2007-07-15       Impact factor: 11.361

Review 4.  The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.

Authors:  Xiang-Jiao Yang; Edward Seto
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

Review 5.  CDK inhibitors: cell cycle regulators and beyond.

Authors:  Arnaud Besson; Steven F Dowdy; James M Roberts
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

6.  Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.

Authors:  Chinmay M Trivedi; Yang Luo; Zhan Yin; Maozhen Zhang; Wenting Zhu; Tao Wang; Thomas Floss; Martin Goettlicher; Patricia Ruiz Noppinger; Wolfgang Wurst; Victor A Ferrari; Charles S Abrams; Peter J Gruber; Jonathan A Epstein
Journal:  Nat Med       Date:  2007-02-18       Impact factor: 53.440

7.  Role for histone deacetylase 1 in human tumor cell proliferation.

Authors:  Silvia Senese; Katrin Zaragoza; Simone Minardi; Ivan Muradore; Simona Ronzoni; Alfonso Passafaro; Loris Bernard; Giulio F Draetta; Myriam Alcalay; Christian Seiser; Susanna Chiocca
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

8.  Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice.

Authors:  Stephan Zimmermann; Franz Kiefer; Michela Prudenziati; Carmen Spiller; Jens Hansen; Thomas Floss; Wolfgang Wurst; Saverio Minucci; Martin Göttlicher
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

9.  Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.

Authors:  Yu Zhang; Sohee Kwon; Teppei Yamaguchi; Fabien Cubizolles; Sophie Rousseaux; Michaela Kneissel; Chun Cao; Na Li; Hwei-Ling Cheng; Katrin Chua; David Lombard; Adam Mizeracki; Gabriele Matthias; Frederick W Alt; Saadi Khochbin; Patrick Matthias
Journal:  Mol Cell Biol       Date:  2008-01-07       Impact factor: 4.272

Review 10.  Shaping genetic alterations in human cancer: the p53 mutation paradigm.

Authors:  Thierry Soussi; Klas G Wiman
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

View more
  143 in total

Review 1.  Histone/protein deacetylases and T-cell immune responses.

Authors:  Tatiana Akimova; Ulf H Beier; Yujie Liu; Liqing Wang; Wayne W Hancock
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

Review 2.  Multiple roles of class I HDACs in proliferation, differentiation, and development.

Authors:  Nina Reichert; Mohamed-Amin Choukrallah; Patrick Matthias
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

3.  HDAC1 and HDAC2 are differentially expressed in endometriosis.

Authors:  Maricarmen Colón-Díaz; Perla Báez-Vega; Miosotis García; Abigail Ruiz; Janice B Monteiro; Jessica Fourquet; Manuel Bayona; Carolina Alvarez-Garriga; Alexandra Achille; Edward Seto; Idhaliz Flores
Journal:  Reprod Sci       Date:  2012-02-16       Impact factor: 3.060

4.  Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis.

Authors:  Roel H Wilting; Eva Yanover; Marinus R Heideman; Heinz Jacobs; James Horner; Jaco van der Torre; Ronald A DePinho; Jan-Hermen Dannenberg
Journal:  EMBO J       Date:  2010-06-22       Impact factor: 11.598

5.  HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.

Authors:  Ludivine Renaud; Lillianne G Harris; Santhosh K Mani; Harinath Kasiganesan; James C Chou; Catalin F Baicu; An Van Laer; Adam W Akerman; Robert E Stroud; Jeffrey A Jones; Michael R Zile; Donald R Menick
Journal:  Circ Heart Fail       Date:  2015-09-14       Impact factor: 8.790

6.  HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity.

Authors:  Wei-Kai Hua; Jing Qi; Qi Cai; Emily Carnahan; Maria Ayala Ramirez; Ling Li; Guido Marcucci; Ya-Huei Kuo
Journal:  Blood       Date:  2017-10-30       Impact factor: 22.113

7.  Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.

Authors:  Mitsuru Seki; Ryan LaCanna; Jeffery C Powers; Christine Vrakas; Fang Liu; Remus Berretta; Geena Chacko; John Holten; Pooja Jadiya; Tao Wang; Jeffery S Arkles; Joshua M Copper; Steven R Houser; Jianhe Huang; Vickas V Patel; Fabio A Recchia
Journal:  J Pharmacol Exp Ther       Date:  2016-06-27       Impact factor: 4.030

Review 8.  Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Authors:  Santosh R D'Mello
Journal:  Dev Neurosci       Date:  2020-01-24       Impact factor: 2.984

9.  Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.

Authors:  Marinus R Heideman; Roel H Wilting; Eva Yanover; Arno Velds; Johann de Jong; Ron M Kerkhoven; Heinz Jacobs; Lodewyk F Wessels; Jan-Hermen Dannenberg
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

10.  Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma.

Authors:  Xilin Du; Huadong Zhao; Li Zang; Nuan Song; Tao Yang; Rui Dong; Jikai Yin; Chengguo Wang; Jianguo Lu
Journal:  Pathol Oncol Res       Date:  2012-12-16       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.